DK0982305T3 - Indan-1-ol-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende derivaterne - Google Patents

Indan-1-ol-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende derivaterne

Info

Publication number
DK0982305T3
DK0982305T3 DK99402092T DK99402092T DK0982305T3 DK 0982305 T3 DK0982305 T3 DK 0982305T3 DK 99402092 T DK99402092 T DK 99402092T DK 99402092 T DK99402092 T DK 99402092T DK 0982305 T3 DK0982305 T3 DK 0982305T3
Authority
DK
Denmark
Prior art keywords
derivatives
alkyl
indan
preparation
pharmaceutical compositions
Prior art date
Application number
DK99402092T
Other languages
English (en)
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Adrian Newman-Tancredi
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK0982305T3 publication Critical patent/DK0982305T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK99402092T 1998-08-21 1999-08-20 Indan-1-ol-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende derivaterne DK0982305T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9810601A FR2782515B1 (fr) 1998-08-21 1998-08-21 NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT

Publications (1)

Publication Number Publication Date
DK0982305T3 true DK0982305T3 (da) 2002-06-24

Family

ID=9529811

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99402092T DK0982305T3 (da) 1998-08-21 1999-08-20 Indan-1-ol-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende derivaterne

Country Status (19)

Country Link
US (1) US6153625A (da)
EP (1) EP0982305B1 (da)
JP (1) JP2000072748A (da)
CN (1) CN1128144C (da)
AT (1) ATE214064T1 (da)
AU (1) AU747494B2 (da)
BR (1) BR9903867A (da)
CA (1) CA2280596A1 (da)
DE (1) DE69900961T2 (da)
DK (1) DK0982305T3 (da)
ES (1) ES2172294T3 (da)
FR (1) FR2782515B1 (da)
HK (1) HK1026212A1 (da)
HU (1) HUP9902784A3 (da)
NO (1) NO317516B1 (da)
NZ (1) NZ337362A (da)
PL (1) PL194852B1 (da)
PT (1) PT982305E (da)
ZA (1) ZA995321B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103646D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chroman compounds
SE0103647D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chromone compounds
WO2002055012A2 (en) * 2001-01-16 2002-07-18 Astrazeneca Ab Therapeutic heterocyclic compounds
EP1353914A2 (en) * 2001-01-16 2003-10-22 AstraZeneca AB Therapeutic chromone compounds
NZ526699A (en) * 2001-01-16 2005-03-24 Astrazeneca Ab 8-amino derivatives and their use in treating migraine
DE10142662B4 (de) * 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
DE10142661B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
DE10142667B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2761358B1 (fr) * 1997-03-27 1999-05-07 Adir Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
FR2782515B1 (fr) 2000-09-22
AU747494B2 (en) 2002-05-16
PL194852B1 (pl) 2007-07-31
JP2000072748A (ja) 2000-03-07
HUP9902784A3 (en) 2001-03-28
HUP9902784A2 (hu) 2000-12-28
CA2280596A1 (fr) 2000-02-21
BR9903867A (pt) 2000-09-05
DE69900961T2 (de) 2002-11-07
NO317516B1 (no) 2004-11-08
HK1026212A1 (en) 2000-12-08
ATE214064T1 (de) 2002-03-15
EP0982305A1 (fr) 2000-03-01
EP0982305B1 (fr) 2002-03-06
PL335012A1 (en) 2000-02-28
ES2172294T3 (es) 2002-09-16
NO994041D0 (no) 1999-08-20
NO994041L (no) 2000-02-22
PT982305E (pt) 2002-07-31
CN1128144C (zh) 2003-11-19
DE69900961D1 (de) 2002-04-11
FR2782515A1 (fr) 2000-02-25
AU4463799A (en) 2000-03-09
US6153625A (en) 2000-11-28
ZA995321B (en) 2000-02-22
HU9902784D0 (en) 1999-10-28
NZ337362A (en) 2000-04-28
CN1250051A (zh) 2000-04-12

Similar Documents

Publication Publication Date Title
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
SE9904738D0 (sv) Novel compounds
PT1263725E (pt) Novos compostos
ATE316083T1 (de) Adamantanderivate
DE60140814D1 (de) N-phenyl-2-pyrimidine-amine derivatives
HUP0301690A2 (hu) Szinergikus eljárások és készítmények rák kezelésére
HUP0101146A2 (hu) Foszfolipáz enzim inhibitor hatású indolszármazékok, valamint a vegyületeket tartalmazó gyógyászati készítmények
SE9903998D0 (sv) New compounds
HUP0400250A2 (hu) 5-HT6 és/vagy 5-HT7 szerotonin receptorok ligandumaként alkalmazott 5-halogén-triptamin-származékok, előállításuk és alkalmazásuk gyógyszerkészítmények előállítására
TR200001973T2 (tr) 11 ß-halojen-7alfa-ile ikame edilmiş-estratrienler, bu 11ß-halojen-7alfa-ile ikame edilmiş-estratrienleri içeren farmasötik terkiplerin üretimi için yöntem ve ilaç üretiminde kullanımları.
ATE300541T1 (de) Pyrazolopyridinderivate
SE9903997D0 (sv) New compounds
DE60001586D1 (de) Diphenyl-piperidin derivate
DK0982305T3 (da) Indan-1-ol-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende derivaterne
HUP0300295A2 (hu) Helyettesített benzamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NO20055997L (no) Diarylmetylidenpiperidinderivater og deres anvendelse som opiodreseptoragonister
ATE274515T1 (de) Pyrazolopyridinderivate
SE9904128D0 (sv) Novel compounds
DE60222465D1 (de) Pyrazolopyridin-derivate als antiherpesmittel
HUP0000966A2 (hu) Izoflavonszármazékok és ilyen vegyületeket hatóanyagként tartalmazó gyógyszerkészítmények
ATE512139T1 (de) Wasserlösliche phenylpyridazinderivate und diese enthaltende arzneimittel
ES2192827T3 (es) Derivados de 8h-(2,3-b)-pirrolicin-8-ona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR019894A1 (es) Empleo de un derivado de tetrahidroxipiridina (0 4-hidroxipiridina) butilazol
HUP9801451A2 (hu) Tetrahidroimidazo[2,1-a]izokinolin-származékok és ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk